Exclusive mutation in EGFR, HER2, and KRAS, and synchronous methylation of non-small cell lung cancer

被引：0
|
作者：
Suzuki, Makoto
Shigematsu, Hisayuki
Iizasa, Toshihiko
Minna, John D.
Fujisawa, Takehiko
Gazdar, Adi F.
机构：
[1] Thorac Surg, Chiba, Japan
[2] Southwestern Med Ctr, Dallas, TX USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
31
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Case of Non-Small Cell Lung Cancer with Mutually Exclusive EGFR and KRAS Mutations
    Tushir, Abhimanyu
    Akhtar, Israh
    Seth, Anjali
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2025, 47 (01)
  • [2] EXPRESSION AND CORRELATION OF EGFR, HER2, KRAS AND RBM5 IN NON-SMALL CELL LUNG CANCER TISSUE
    Wang, K.
    Zhang, J.
    Liang, H.
    Chen, S.
    Xu, W.
    Sutherland, L. C.
    RESPIROLOGY, 2011, 16 : 150 - 150
  • [3] EGFR and HER2/NEU in gefitinib chemotherapy for non-small cell lung cancer
    Yoo, J.
    HISTOPATHOLOGY, 2008, 53 : 406 - 406
  • [4] The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer
    Nagasaka, Misako
    Singh, Vijendra
    Baca, Yasmine
    Sukari, Ammar
    Kim, Chul
    Mamdani, Hirva
    Spira, Alexander, I
    Uprety, Dipesh
    Bepler, Gerold
    Kim, Edward S.
    Raez, Luis E.
    Pai, Sachin Gopalkrishna
    Ikpeazu, Chukwuemeka
    Oberley, Matthew
    Feldman, Rebecca
    Xiu, Joanne
    Korn, W. Michael
    Wozniak, Antoinette J.
    Borghaei, Hossein
    Liu, Stephen, V
    CLINICAL LUNG CANCER, 2022, 23 (01) : 52 - 59
  • [5] EGFR and HER2 mutation and gene amplification in non-small-cell lung cancer
    Toshihiko, Yokoyama
    Kondo, Masashi
    Goto, Yasuhiro
    Fukui, Takayuki
    Yoshioka, Hiromu
    Yokoi, Kohei
    Kondo, Yutaka
    Osada, Hirotaka
    Imaizumi, Kazuyoshi
    Hasegawa, Yoshinori
    Shimokata, Kaoru
    Sekido, Yoshitaka
    CANCER RESEARCH, 2006, 66 (08)
  • [6] Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells
    Moody, Terry W.
    Ramos-Alvarez, Irene
    Moreno, Paula
    Mantey, Samuel A.
    Ridnour, Lisa
    Wink, David
    Jensen, Robert T.
    PEPTIDES, 2017, 90 : 90 - 99
  • [7] Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer
    Suzuki, M
    Shigematsu, H
    Iizasa, T
    Hiroshima, K
    Nakatani, Y
    Minna, JD
    Gazdar, AF
    Fujisawa, T
    CANCER, 2006, 106 (10) : 2200 - 2207
  • [8] Characteristics and predictive modeling of HER2 mutation in patients with non-small cell lung cancer
    Varolgunes, Uras
    Mittal, Garima
    Parikh, Kaushal
    Ip, Andrew
    Malhotra, Jyoti
    Bates, Benjamin
    Salas, Maribel
    Arunachalam, Meena
    Chen, Haoqian
    Chen, Wenjin
    Yu, Dantong
    Setoguchi, Soko
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] KRAS mutation is highly correlated with EGFR alterations in patients with non-small cell lung cancer
    Wang, J. -Y.
    Lin, S. -R.
    EJC SUPPLEMENTS, 2009, 7 (04): : 37 - 37
  • [10] Plasma EGFR and Her2 levels in non-small cell lung cancer patients treated with gefitinib
    Kasahara, K.
    Tamori, S.
    Sakai, A.
    Tambo, Y.
    Araya, T.
    Sone, T.
    Kimura, H.
    Fujimura, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345